NovoCure Ltd. (NVCR)
10.47
+0.44
(+4.39%)
USD |
NASDAQ |
Feb 10, 16:00
10.58
+0.11
(+1.05%)
After-Hours: 20:00
NovoCure EPS Diluted (Quarterly) : -0.333 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| LivaNova Plc | 0.4856 |
| Abbott Laboratories | 1.017 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1888 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.27M |
| Revenue (Quarterly) | 167.20M |
| Total Expenses (Quarterly) | 204.47M |
| Enterprise Value | 934.37M |
| Gross Profit Margin (Quarterly) | 73.25% |
| Profit Margin (Quarterly) | -22.29% |
| Earnings Yield | -15.39% |
| Normalized Earnings Yield | -15.34 |